APOE and atherosclerosis: We approached this by assessing the effect of elevating the plasma levels of CCN4, to observe the effects on an already established plaque, as well as deletion of CCN4 to completely remove plasma CCN4, to observe the effect on plaque development, using the fat fed ApoE−/− mouse in vivo model of atherosclerosis.